期刊
NEUROPHARMACOLOGY
卷 89, 期 -, 页码 168-174出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2014.05.009
关键词
Gliomas; Radiation sensitivity; HIF-1 alpha; RNAi; Pathway
资金
- National Natural Science Foundation of China [81072083]
Gliomas are the leading cause of cancer-related mortality worldwide, and the incidence is increasing. Because gliomas often become resistant to radiation treatment, it is urgent to develop novel therapeutic methods that are more effective and less toxic than current therapies so as to enhance patient survival and quality of life. Effective enhancement of radiation therapy for gliomas in vivo and in vitro was observed upon silencing of hypoxia-inducible factor 1 alpha (HIF-1 alpha) with RNA interference; this enhancement was related to changes in the cell cycle and apoptosis that were accompanied by modulation of Cdc2, cyclin B1, and Bcl-2 expression. Our data suggest that HIF-1 alpha silencing combined with radiation therapy will increase the.therapeutic efficacy of glioma treatment via regulation of cell cycle and apoptosis-related signaling pathways. (C) 2014 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据